Literature DB >> 17307114

Inactivity and inflammation in the critically ill patient.

Chris Winkelman1.   

Abstract

Bed rest is a commonly prescribed activity restriction among patients in the ICU. Although bed rest may promote rest, recovery and safety, inactivity related to bed rest also may lead to complications and adverse outcomes. The biological mechanisms that lead to immediate and long-term sequelae from bed rest have not been elucidated. It may be the inflammatory factors common to critical illness combined with bed rest lead to a positive feedback loop, contributing to inflammatory disequilibrium. This disequilibrium has a profound affect on muscles. Muscle decay has serious and long-term adverse outcomes on survivors of critical illness. Mobility therapy may improve inflammatory disequilibrium and preserve muscles, leading to improved functional outcome. Investigations in the laboratory, in healthy people and among patients with systemic inflammatory disease, suggest that activity does not exacerbate inflammation. Clinically, exercise is beneficial to patients with various chronic inflammatory diseases. Further study is needed to best understand the role, duration, and frequency of activity in promoting recovery for critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307114     DOI: 10.1016/j.ccc.2006.11.002

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  24 in total

Review 1.  Persistent systemic inflammation in chronic critical illness.

Authors:  Christopher E Cox
Journal:  Respir Care       Date:  2012-06       Impact factor: 2.258

Review 2.  Mobilization in severe sepsis: an integrative review.

Authors:  Sushant Govindan; Theodore J Iwashyna; Andrew Odden; Scott A Flanders; Vineet Chopra
Journal:  J Hosp Med       Date:  2015-01       Impact factor: 2.960

3.  Effects of spaceflight on innate immune function and antioxidant gene expression.

Authors:  Farnaz P Baqai; Daila S Gridley; James M Slater; Xian Luo-Owen; Louis S Stodieck; Virginia Ferguson; Stephen K Chapes; Michael J Pecaut
Journal:  J Appl Physiol (1985)       Date:  2009-04-02

4.  Patient-related factors associated with hospital discharge to a care facility after critical illness.

Authors:  Brian K Gehlbach; Victor R Salamanca; Joseph E Levitt; Greg A Sachs; Mary Kate Sweeney; Anne S Pohlman; Jeff Charbeneau; Jerry A Krishnan; Jesse B Hall
Journal:  Am J Crit Care       Date:  2011-09       Impact factor: 2.228

Review 5.  The effects of active mobilisation and rehabilitation in ICU on mortality and function: a systematic review.

Authors:  Claire J Tipping; Meg Harrold; Anne Holland; Lorena Romero; Travis Nisbet; Carol L Hodgson
Journal:  Intensive Care Med       Date:  2016-11-18       Impact factor: 17.440

Review 6.  Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings.

Authors:  Joaquim Gea; Sergi Pascual; Carme Casadevall; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

7.  [Impact of hospitalization in an intensive care unit on range of motion of critically ill patients: a pilot study].

Authors:  Balbino Rivail Ventura Nepomuceno; Bruno Prata Martinez; Mansueto Gomes Neto
Journal:  Rev Bras Ter Intensiva       Date:  2014 Jan-Mar

8.  A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle.

Authors:  Hannah Crossland; Dumitru Constantin-Teodosiu; Sheila M Gardiner; Despina Constantin; Paul L Greenhaff
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

9.  Four weeks of mobility after 8 weeks of immobility fails to restore normal motion: a preliminary study.

Authors:  Guy Trudel; Jian Zhou; Hans K Uhthoff; Odette Laneuville
Journal:  Clin Orthop Relat Res       Date:  2008-02-26       Impact factor: 4.176

10.  Joint contracture following prolonged stay in the intensive care unit.

Authors:  Heidi Clavet; Paul C Hébert; Dean Fergusson; Steve Doucette; Guy Trudel
Journal:  CMAJ       Date:  2008-03-11       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.